


A new target to fight certain aggressive leukaemias
A new target to fight certain aggressive leukaemias Acute Myeloid Leukemia, FLT3, C/AAT-enhancer binding protein α, Jean-Emmanuel Sarry Team METAML- Metabolism and Therapeutic Resistance In Acute Myeloid Leukemia . Researchers from the Toulouse Cancer Research...
Recent discoveries on the cholesterol metabolic pathway
Recent discoveries on the cholesterol metabolic pathway LIPID Metabolites And Pathways Strategy (LIPID MAPS®) is an institutionally supported website and database that provides access to a large number of lipidomic resources used worldwide. Since 2003, LIPID MAPS® has...
Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer
Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer Pancreatic cancer, non-viral gene therapy, resistance to treatment, chemotherapy, preclinical regulatory experiments. Pierre Cordelier Team ImPact- Therapeutic innovation in...
Acquired genetic abnormalities predict outcome in patients with GATA2 deficiency
Acquired genetic abnormalities predict outcome in patients with GATA2 deficiency GATA2, leukemic transformation, clonal hematopoiesis, STAG2, genotype-phenotype correlation, Laétitia Largeaud team IGGALD- Impact of genetic alterations on acute leukemia development...